Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
812.00    4.00 (0.50%)
Bid:
810.00
Ask:
812.00
Spread: 2.00 (0.247%)
Market Cap: £1.13b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

AGM Statement

8 May 2018 12:00

RNS Number : 3728N
Savills PLC
08 May 2018
 

 

8 May 2018

SAVILLS PLC

("Savills" or "the Company")

 

AGM Statement

 

Savills plc, the international real estate advisor, is today holding its Annual General Meeting (AGM) at 2.30pm, 33 Margaret Street, London, W1G 0JD, and provides the following AGM statement.

 

During the year to date Savills has traded in line with our expectations. Globally, our transaction businesses have continued to maintain a strong market share although, as anticipated, there is a tendency for transactions to take longer to complete. Our Consultancy and Property Management businesses have continued to perform well.

 

In the UK, trading was slightly ahead of our expectations principally down to strong performances in Central London Commercial transactions and from our portfolio of Less Transactional businesses including property management. UK commercial markets more generally are seeing greater uncertainty and a relative lack of stock which has reduced transaction levels. The residential market had a very quiet start to the year, however we have seen stronger levels of activity since the middle of March.

 

In Asia Pacific, Savills has had a good start to the year, despite adverse currency movements. Hong Kong and Korea have performed well offsetting slight declines in activity in Australia and Japan.

 

In the US, Savills Studley has had a slower start to the year than initially anticipated with the timing of transactions resulting in weaker volumes in New York and Washington. This offset stronger growth in other markets, notably California and New Jersey. Overall we have a good pipeline of instructions. 

 

In Continental Europe, to date we have traded marginally behind our expectations, again due to delays in transactions, with stronger than anticipated performances in Germany, Netherlands and Sweden, largely offsetting slower performances in France and Poland and the continuing start-up costs in the Czech Republic. In Spain, the integration of Aguirre Newman has gone well and generally across the European business, pipeline activity is solid.

 

Savills Investment Management has performed as expected with a good pipeline of product launches.

 

Whilst we have started the year as expected, typically the first four months represent a disproportionately small element of the expected outturn for the full year. Consequently, at this stage in the year, we continue to anticipate overall performance to be in line with our expectations.

 

 

For further information, contact:

 

Savills 020 7409 8934

Jeremy Helsby, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications 020 7353 4200

Peter Hewer

Will Palfreyman

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMLLFEIELITIIT
Date   Source Headline
2nd Dec 202410:00 amRNSTotal Voting Rights
26th Nov 20243:34 pmRNSHolding(s) in Company
22nd Nov 20242:00 pmRNSAdditional Listing
15th Nov 20242:58 pmRNSHolding(s) in Company
14th Nov 20241:53 pmRNSHolding(s) in Company
13th Nov 20241:47 pmRNSHolding(s) in Company
12th Nov 20242:51 pmRNSDirector/PDMR Shareholding
12th Nov 20242:48 pmRNSHolding(s) in Company
11th Nov 20242:25 pmRNSHolding(s) in Company
1st Nov 202411:00 amRNSTotal Voting Rights
14th Oct 20249:52 amRNSDirector/PDMR Shareholding
4th Oct 20242:00 pmRNSAdditional Listing
1st Oct 202411:00 amRNSTotal Voting Rights
18th Sep 20242:43 pmRNSDirector Declaration
16th Sep 20243:50 pmRNSDirector Declaration
12th Sep 20241:47 pmRNSDirector/PDMR Shareholding
2nd Sep 202411:00 amRNSTotal Voting Rights
29th Aug 20242:24 pmRNSDirector/PDMR Shareholding
15th Aug 202411:00 amRNSBlock listing Interim Review
13th Aug 20243:17 pmRNSDirector/PDMR Shareholding
8th Aug 20247:00 amRNSHalf-year Report
1st Aug 202411:00 amRNSTotal Voting Rights
30th Jul 20242:11 pmRNSHolding(s) in Company
22nd Jul 20242:36 pmRNSBlock listing Interim Review
11th Jul 20244:26 pmRNSDirector/PDMR Shareholding
1st Jul 20249:27 amRNSTotal Voting Rights
20th Jun 202410:36 amRNSDirector/PDMR Shareholding
13th Jun 20241:37 pmRNSDirector/PDMR Shareholding
11th Jun 20244:42 pmRNSDirector/PDMR Shareholding
7th Jun 20244:01 pmRNSDirector/PDMR Shareholding
4th Jun 20242:43 pmRNSDirector/PDMR Shareholding
3rd Jun 202411:00 amRNSTotal Voting Rights
23rd May 20242:21 pmRNSDirector/PDMR Shareholding
17th May 20243:44 pmRNSDirector/PDMR Shareholding
15th May 20243:06 pmRNSResult of AGM
15th May 202410:02 amRNSAGM Statement
14th May 20248:00 amRNSDirector/PDMR Shareholding
2nd May 20248:28 amRNSTotal Voting Rights
26th Apr 20242:13 pmRNSDirector/PDMR Shareholding
26th Apr 202411:21 amRNSDirector Declaration
15th Apr 20243:42 pmRNSDirector/PDMR Shareholding
12th Apr 20245:12 pmRNSDirector/PDMR Shareholding
8th Apr 20243:47 pmRNSAnnual Report and AGM Notice
21st Mar 20248:17 amRNSDirector/PDMR Shareholding
19th Mar 20245:11 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSNon-Executive Director Appointment
14th Mar 20247:00 amRNSFinal Results
13th Mar 20241:37 pmRNSDirector/PDMR Shareholding
15th Feb 202410:00 amRNSBlock listing Interim Review
13th Feb 20246:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.